Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 3 , Pages 355-367, September 2006

Insulin resistance in hypertension and cardiovascular disease

Department of Endocrinology, Diabetes and Metabolism, University Medical Center, University of Dresden, 01307 Dresden, Germany

Department of Internal Medicine III, University Medical Center, University of Dresden, 01307 Dresden, Germany

Insulin resistance is not simply a problem of decreased glucose uptake in response to insulin, but a multifaceted syndrome that significantly increases the risk for cardiovascular disease. Insulin resistance is strongly associated with arterial hypertension and a pathogenetic role in the development of arterial hypertension has been suggested. One question that remains open concerns the clinical approach to insulin-resistant patients. Observational and clinical trial data suggest that lifestyle changes including weight reduction and regular physical activity can improve insulin sensitivity and reduce the incidence and mortality of cardiovascular disease. Daily physical activity of moderate intensity for 30min has a cardioprotective effect and reduces insulin resistance, independent of the effect on body weight. A pharmacological therapy for insulin resistance reducing cardiovascular disease remains to be defined. Concerning the antihypertensive therapy of insulin-resistant hypertensive patients, most hypertensive guidelines fail to provide specific advice.

Key words: insulin resistance, obesity, hypertension, cardiovascular disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(06)00048-0

doi:10.1016/j.beem.2006.07.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 3 , Pages 355-367, September 2006